Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys.
Dienogest is a selective progestin that has been shown to arrest ovarian follicular development in women, without affecting gonadotropin secretion. As luteal progesterone or exogeneous progestins are known to suppress ovarian folliculogenesis via the inhibition of gonadotropin secretion, this action of dienogest on ovaries seems to be unique. To examine the underlying mechanism of the antifolliculogenic effect of dienogest, female cynomolgus monkeys were treated with a single oral dose of 0.1 mg/kg dienogest on day 7 of the menstrual cycle. Plasma FSH, estradiol (E2), and progesterone levels were measured up to 15 days after dosing. In an additional experiment, ovaries were excised 24 h after dosing for histological examinations. As a result, plasma E2 level declined within 24 h after dosing, while dienogest did not decreased FSH level prior to E2 decline. After decline of E2 level, the low level of E2 was sustained for more than 11 days. It is considered that a single oral dose of dienogest induced atresia of the dominant follicle. In the histological examination, two out of three animals showed decline in E2 level. The ovarian dominant follicles from these animals showed apoptotic changes in granulosa cells with scattered aromatase expression within 24 h after dosing. These results indicate that the induction of atresia of the ovarian dominant follicle by direct action would be a possible mechanism of dienogest to inhibit plasma E2 level.
Sasagawa
S
S
Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan.
Shimizu
Y
Y
Nagaoka
T
T
Tokado
H
H
Imada
K
K
Mizuguchi
K
K
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D004958:Estradiol / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D005496:Follicular Atresia / Q000378:metabolism; D006107:Granulosa Cells / Q000187:drug effects / Q000502:physiology; D006727:Hormone Antagonists / Q000494:pharmacology*; D006801:Humans; D008252:Macaca fascicularis; D008597:Menstrual Cycle / Q000502:physiology; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000494:pharmacology; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D011374:Progesterone / Q000097:blood; D011372:Progestins / Q000494:pharmacology
D006727:Hormone Antagonists; D011372:Progestins; C023635:dienogest; D011374:Progesterone; D004958:Estradiol; D009277:Nandrolone; D005640:Follicle Stimulating Hormone
Indian J Exp Biol. 1989 Apr;27(4):324-8
2530166
Endocrinology. 1980 Jun;106(6):1820-6
6768544
Mol Cell Endocrinol. 1993 Nov;97(1-2):135-43
8143896
Rev Reprod. 1997 Sep;2(3):139-46
9414477
Endocrinology. 1983 Jun;112(6):2076-80
6406208
Fertil Steril. 2006 Jul;86(1):27-35
16764869
Endocrinology. 1979 Jul;105(1):69-79
109289
Fertil Steril. 1983 Nov;40(5):688-92
6628715
J Clin Endocrinol Metab. 1971 Mar;32(3):309-16
5541341
Maturitas. 2004 Apr 15;47(4):277-83
15063480
J Clin Endocrinol Metab. 1977 Oct;45(4):837-40
410825
Drugs Exp Clin Res. 1997;23(2):45-62
9309380
Am J Physiol. 1982 Nov;243(5):E387-97
6814263
Fertil Steril. 2001 Apr;75(4):744-8
11287029
Am J Physiol. 1981 May;240(5):E489-92
6786104
Zentralbl Gynakol. 1997;119(12):597-606
9483810
Proc Soc Exp Biol Med. 1977 Sep;155(4):479-81
408814
Biol Reprod. 1981 Sep;25(2):332-41
6796137
Biol Reprod. 2007 Oct;77(4):743-50
17582010
J Clin Endocrinol Metab. 1984 Feb;58(2):378-83
6420438
Contraception. 1980 Jan;21(1):61-9
7357870
Mol Cell Endocrinol. 2007 Jan 29;264(1-2):197-203
17116363
Reproduction. 2006 Aug;132(2):191-206
16885529
J Clin Endocrinol Metab. 1980 Oct;51(4):903-7
7419672
Acta Eur Fertil. 1979 Mar;10(1):29-33
121012
Endocrinology. 1994 Aug;135(2):569-75
8033804